Ind-Swift Laboratories Ltd. — Major Shareholding Notification 2025

Jul 4, 2025

==> picture [476 x 85] intentionally omitted <==

Ref: ISLL:CH:2025

Date: 4[th] July, 2025

The President The Vice President, Corporate Relationship Department Listing Compliance Department, BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] Floor 25[th] Floor, Dalal Street, Plot No. C/2, G-Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (E), Mumbai 400 051

ISIN: INE915B01019, INE915B07024 BSE Scrip Code: 532305, 957989 NSE Symbol: INDSWFTLAB

Subject: Disclosures under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011

Dear Sir/Ma’am,

Please find enclosed herewith disclosure under Regulation 29(1) of SEBI (Substantial acquisition of Shares and Takeover) Regulations, 2011 received by the Company on 3[rd] July, 2025 from Zeal Global Opportunities Fund.

You are requested to take the same on your record.

Thanking you,

For IND-SWIFT LABORATORIES LTD.

Pardeep Digitally signed by Pardeep Verma Verma Date: 2025.07.04 10:09:15 +05'30' PARDEEP VERMA VP-CORPORATE AFFAIRS & COMPANY SECRETARY Encl: a/a

==> picture [165 x 40] intentionally omitted <==

Date: 3[rd] July 2025

BSE Limited Phiroze Jeejeebhoy Towers, 25[th] Floor, Dalal Street, Mumbai 400 001

National Stock Exchange of India Limited, Exchange Plaza, 5[th] Floor Plot No. C/2, G-Block, Bandra Kurla Complex, Bandra (E), Mumbai 400 051

BSE Scrip Code: 532305

NSE Symbol: INDSWFTLAB

Subject: Intimation of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011

Respected

Please find enclosed herewith disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 w.r.t. to acquisition of 24,68,000 equity shares of Ind 3.67% of the total paid-up share capital of the target company, upon conversion of equivalent no. of warrants into equity.

With this conversion, our total holding in the company has increased from 2.53% to 5.95%.

You are requested to kindly take the same on record.

Thanking You For Zeal Global Opportunities Fund

==> picture [45 x 36] intentionally omitted <==

Name: Nikhil Kumar Designation Authorized Signatory

CC: Company Secretary & Compliance Officer Ind Swift Laboratories Limited SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh 160101

Zeal Global Opportunities Fund

Registered Address: Level 5, Maeva Tower, Bank Street, Cybercity, Ebène, Republic of Mauritius. Business Address: 6th floor , Orbis court, 132 ,St Jean Road , Quatre Bornes , Mauritius Mob: (230) 55026006 Fax: (230) 467 8858 Email: Backoffice@zinniafunds.com

Format for disclosures under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Part-A - Details of the Acquisition

==> picture [443 x 577] intentionally omitted <==

----- Start of picture text -----

Name of the Target Company (TC) Ind-Swift Laboratories Limited
Name(s) of the acquirer and Persons Zeal Global Opportunities Fund
Acting in Concert (PAC) with the
acquirer
Whether the acquirer belongs to No
Promoter / Promoter group
Name(s) of the Stock Exchange(s)
BSE Limited & National Stock Exchange of
where the shares of TC are Listed India Limited
Details of the acquisition as follows Number % w.r.t. total % w.r.t. total
share/voting diluted
capital share/voting
wherever capital of the
applicable () TC ()
Before the acquisition under
consideration, holding of acquirer
along with PACs of:
#
a) Shares carrying voting rights 15,32,000 2.53% 4.70%
b) Shares in the nature of
encumbrance (pledge/ lien/ non- - - -
disposal undertaking/ others)
c) Votingby shares rights (VR) otherwise than - - -
d) Warrants/convertible securities/any - -
other instrument that entitles the [24,68,000 ]
acquirer to receive shares carrying
voting rights in the TC (specify
holding in each category)
e) Total (a+b+c+d) 40,00,000 2.53% 4.70%
Details of acquisition
#
a) Shares carrying voting rights 3.67% 4.70%
24,68,000
acquired
b) VRs acquired otherwise than by - - -
equity shares
c) Warrants/convertible securities/anyother instrument that entitles the - - -
acquirer to receive shares carrying
voting rights in the TC (specify
holding in each category) acquired
----- End of picture text -----*

==> picture [444 x 627] intentionally omitted <==

----- Start of picture text -----

d) Shares in the nature of - - -
encumbrance (pledge/ lien/ non-
disposal undertaking/ others)
e) Total (a+b+c+/-d) 24,68,000 3.67% 4.70%
After the acquisition, holding of
acquirer along with PACs of:
#
a) Shares carrying voting rights 40,00,000 5.95% 4.70%
b) VRs otherwise than by equity - _
shares
c) Warrants/convertible securities
/any other instrument that - _
entitles the acquirer to receive
shares carrying voting rights in
the TC (specify holding in each
category) after acquisition
d) Shares in the nature of - _ _
encumbrance (pledge/ lien/ non-
disposal undertaking/ others)
e) Total (a+b+c+d) 40,00,000 5.95% 4.70%
Mode of acquisition (e.g. open market / Preferential Allotment upon conversion of
public issue / rights issue / preferential warrants into equity
allotment / inter-se transfer /
encumbrance, etc.)
Salient features of the securities Acquisition of equity shares upon conversion
acquired including time till redemption, of warrants into equity
ratio at which it can be converted into
equity shares, etc.
Date of acquisition of / date of receipt of
intimation of allotment of shares / VR/ 02-07-2025
warrants/convertible securities/any
other instrument that entitles the
acquirer to receive shares in the TC.
Equity share capital / total voting capital
Rs. 60,61,88,600/- comprising of 6,06,18,860
of the TC before the said acquisition
equity shares of face value of Rs. 10/- each.
Equity share capital/ total voting capital
Rs. 67,21,07,360/- comprising of 6,72,10,736
of the TC after the said acquisition
equity shares of face value of Rs. 10/- each.
Total diluted share/voting capital of the
Rs. 85,08,68,600/- comprising of 8,50,86,860
TC after the said acquisition
equity shares of face value of Rs. 10/- each.
----- End of picture text -----

Assuming full conversion of total outstanding warrants.